drug costs

The recent approval of a new Alzheimer’s drug by the U.S. Food and Drug Administration (FDA) has sparked a significant conversation about the cost and efficacy of treatments for this debilitating disease. With nearly 7 million Americans suffering from Alzheimer’s, the introduction of Eli Lilly’s new drug, Kisunla, offers a glimmer of hope. However, the […]